The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Monthly Archives: August 2010

Gone Fishing

I am taking a break from the online world for a couple of weeks and will be back after Labo(u)r Day. Until then, check out the industry trends pages or my Twitter list of biopharma and health news sources. See you in September!

Monday Biotech Deal Review: August 16, 2010

Another decent week for Canada’s biotech companies, with about $30 million of securities sold and more deals launched. Big headlines this week for Alectos’ Alzheimer’s collaboration with Merck, which gets a US$289 million number but declines to split out the up-front payment or other details of the fee structure. Also, eHealth Ontario is spending significant [...]

This Week in the Twitterverse

Here’s some reading for the weekend from our Twitter stream on @crossborderbio: RT @FiercePharma: Genomics might have rescued Sanofi diet drug.http://bit.ly/d18EFp 14 hours ago YM Biosciences’ Phase II JAK1/2 inhibitor gets orphan drug designation for myelofibrosis http://bit.ly/aFD4xc1 day ago Final Call for Abstracts (Deadline Extended): Canadian Science Policy Conference 2010 – Deadline Aug 29th, 2010 http://bit.ly/9EB34b 2 days ago Merck in Canada: $289m Alzheimer’s [...]

Ontario Emerging Technologies Fund (OETF) Shows Signs of Life (Sciences), Adds Biotech Investments and Investors

An announcement this morning from the OETF — Ontario’s (née) $250 million co-investment fund – shows positive signs for potential matching investments in the life sciences. First, the OETF announced an investment in Natrix Separations. BDC wore the “Qualified Investor” hat on that one, but Natrix is in GrowthWorks’ Canadian Fund portfolio, so we know at [...]

Monday Biotech Deal Review: August 9, 2010

Catching up from the long weekend last week, we have a full two weeks’ worth of deals to bring you. Highlights include $16.7 million of securities closings, $8.25 million launched; and interesting developments in the Forbes Medi-Tech and Northstar Healthcare acquisitions. Check out what the last two weeks have wrought…

This Week in the Twitterverse

Even though posts have dropped off between the long weekend last week and some business travel, I’ve been keeping Twitter up to date and will resume with a two-week deal review on Monday. In the meantime, here’s some reading to catch up on: RT @PharmProEditor: Patheon Signs Technology Transfer Agreement with Dendreon http://bit.ly/aWElIg RT @OntInnovation: RT [...]

Follow

Get every new post delivered to your Inbox.

Join 76 other followers